JPH0547219B2 - - Google Patents
Info
- Publication number
- JPH0547219B2 JPH0547219B2 JP60023983A JP2398385A JPH0547219B2 JP H0547219 B2 JPH0547219 B2 JP H0547219B2 JP 60023983 A JP60023983 A JP 60023983A JP 2398385 A JP2398385 A JP 2398385A JP H0547219 B2 JPH0547219 B2 JP H0547219B2
- Authority
- JP
- Japan
- Prior art keywords
- stress
- blood vessel
- artificial blood
- strain
- elastomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004204 blood vessel Anatomy 0.000 claims description 147
- 239000002473 artificial blood Substances 0.000 claims description 104
- 229920001971 elastomer Polymers 0.000 claims description 75
- 239000000806 elastomer Substances 0.000 claims description 73
- 239000000835 fiber Substances 0.000 claims description 41
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 16
- 230000015271 coagulation Effects 0.000 claims description 11
- 238000005345 coagulation Methods 0.000 claims description 11
- 238000005192 partition Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 description 45
- 239000011148 porous material Substances 0.000 description 28
- 239000000463 material Substances 0.000 description 25
- 239000002904 solvent Substances 0.000 description 22
- 239000011521 glass Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 210000001367 artery Anatomy 0.000 description 12
- -1 polydimethylsiloxane Polymers 0.000 description 12
- 229920002635 polyurethane Polymers 0.000 description 11
- 239000004814 polyurethane Substances 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- 230000002785 anti-thrombosis Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000000250 revascularization Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001112 coagulating effect Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 229920002334 Spandex Polymers 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000004759 spandex Substances 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 238000009864 tensile test Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001036794 Microsorum maximum Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241001111421 Pannus Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920003226 polyurethane urea Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60023983A JPS61185271A (ja) | 1985-02-09 | 1985-02-09 | コンプライアンスおよび応力−歪曲線が生体血管に近似している人工血管およびその製造方法 |
| DE8585102228T DE3566498D1 (en) | 1984-03-01 | 1985-02-28 | Artificial vessel and process for preparing the same |
| EP85102228A EP0157178B1 (fr) | 1984-03-01 | 1985-02-28 | Vaisseau artificiel et procédé pour sa préparation |
| CN 85101355 CN85101355A (zh) | 1985-01-29 | 1985-04-01 | 人造血管及其制做工艺 |
| US07/165,365 US4857069A (en) | 1984-03-01 | 1988-02-29 | Artificial vessel and process for preparing the same |
| US07/371,874 US4954127A (en) | 1984-03-01 | 1989-06-26 | Process for preparing an artificial vessel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60023983A JPS61185271A (ja) | 1985-02-09 | 1985-02-09 | コンプライアンスおよび応力−歪曲線が生体血管に近似している人工血管およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61185271A JPS61185271A (ja) | 1986-08-18 |
| JPH0547219B2 true JPH0547219B2 (fr) | 1993-07-16 |
Family
ID=12125799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60023983A Granted JPS61185271A (ja) | 1984-03-01 | 1985-02-09 | コンプライアンスおよび応力−歪曲線が生体血管に近似している人工血管およびその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61185271A (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8708476D0 (en) * | 1987-04-09 | 1987-05-13 | Charlesworth D | Making polymer material |
| US5549664A (en) * | 1990-07-31 | 1996-08-27 | Ube Industries, Ltd. | Artificial blood vessel |
| US6056993A (en) * | 1997-05-30 | 2000-05-02 | Schneider (Usa) Inc. | Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel |
| DE69839885D1 (de) * | 1997-09-08 | 2008-09-25 | Terumo Corp | Blutgefässprothese |
| AU2002360048A1 (en) | 2001-12-25 | 2003-07-15 | Keiji Hiramatsu | Generator |
| WO2003065996A2 (fr) * | 2002-02-05 | 2003-08-14 | Cambridge Scientific, Inc. | Compositions osteoconductrices bioresorbables destinees a la regeneration osseuse |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57150954A (en) * | 1981-02-13 | 1982-09-17 | Thoratec Lab Corp | Artery implant prosthesis |
-
1985
- 1985-02-09 JP JP60023983A patent/JPS61185271A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57150954A (en) * | 1981-02-13 | 1982-09-17 | Thoratec Lab Corp | Artery implant prosthesis |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61185271A (ja) | 1986-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0157178B1 (fr) | Vaisseau artificiel et procédé pour sa préparation | |
| EP0216149B1 (fr) | Vaisseaux artificiels | |
| US5549664A (en) | Artificial blood vessel | |
| EP1443982B1 (fr) | Protheses polymeriques poreuses et procedes de fabrication | |
| EP0128501B1 (fr) | Vaisseau artificiel et son procédé de préparation | |
| US4871361A (en) | Artificial vessel | |
| JPH0547219B2 (fr) | ||
| JPS61238238A (ja) | 人工血管の製造方法 | |
| JPH0262264B2 (fr) | ||
| JPH0228337B2 (fr) | ||
| JPH0261260B2 (fr) | ||
| EP0217115B1 (fr) | Vaisseau artificiel | |
| JPH0231988B2 (fr) | ||
| WO1992002195A1 (fr) | Vaisseau sanguin artificiel et procede de production associe | |
| JPS61244345A (ja) | 人工血管の製造法 | |
| JPH0233263B2 (fr) | ||
| JPS6395050A (ja) | 人工血管 | |
| JPS602257A (ja) | 新規な人工血管 | |
| JPS61176353A (ja) | コンプライアンスおよび応力−歪曲線が生体血管に近似している人工血管 | |
| JPH0228979B2 (fr) | ||
| JPS602254A (ja) | 人工血管およびその製造法 | |
| JPS60182957A (ja) | 人工血管の製造方法 | |
| JPH0471547B2 (fr) | ||
| EP0941739A1 (fr) | Matériau pour implant artificiel, revêtu et procédé pour sa préparation | |
| JPH0228338B2 (fr) |